Related references
Note: Only part of the references are listed.Comparison of the effects on glycaemic control and beta-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study)
W. Xu et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Vitamin D deficiency, serum leptin and osteoprotegerin levels in older diabetic patients: an input to new research avenues
Stefania Maggi et al.
ACTA DIABETOLOGICA (2014)
Effects of correction of vitamin D insufficiency on serum osteocalcin and glucose metabolism in obese children
Preamrudee Poomthavorn et al.
CLINICAL ENDOCRINOLOGY (2014)
Serum levels of bone resorption markers are decreased in patients with type 2 diabetes
Rebeca Reyes-Garcia et al.
ACTA DIABETOLOGICA (2013)
Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals
Alison R. Meloni et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Diabetes and bone health
Marianna Antonopoulou et al.
MATURITAS (2013)
A five-year prospective study of bone mineral density in men and women with diabetes: The Fremantle Diabetes Study
Emma J. Hamilton et al.
ACTA DIABETOLOGICA (2012)
Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) A 26-week double-blind study
David Russell-Jones et al.
DIABETES CARE (2012)
Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland
Belinda Gier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients
Mathijs C. Bunck et al.
JOURNAL OF DIABETES (2012)
Regulation of glucose metabolism and the skeleton
Kong Wah Ng
CLINICAL ENDOCRINOLOGY (2011)
Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes
M. C. Bunck et al.
DIABETES OBESITY & METABOLISM (2011)
Incretin Receptors in Non-Neoplastic and Neoplastic Thyroid C Cells in Rodents and Humans: Relevance for Incretin-Based Diabetes Therapy
Beatrice Waser et al.
NEUROENDOCRINOLOGY (2011)
Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus
I. Kanazawa et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Bone and glucose metabolism: A two-way street
Katherine J. Motyl et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism
Mathieu Ferron et al.
CELL (2010)
Presence of a Functional Receptor for GLP-1 in Osteoblastic Cells, Independent of the cAMP-Linked GLP-1 Receptor
Bernardo Nuche-Berenguer et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states
Bernardo Nuche-Berenguer et al.
REGULATORY PEPTIDES (2010)
Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances
Meena Asmar et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Bone Loss in Diabetes: Use of Antidiabetic Thiazolidinediones and Secondary Osteoporosis
Beata Lecka-Czernik
Current Osteoporosis Reports (2010)
Thiazolidinediones and Fractures in Men and Women
Colin R. Dormuth et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States
Bernardo Nuche-Berenguer et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
One-year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients A randomized, controlled trial
Mathijs C. Bunck et al.
DIABETES CARE (2009)
Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men
Jenny M. Kindblom et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Adiponectin Is Associated with Changes in Bone Markers during Glycemic Control in Type 2 Diabetes Mellitus
Ippei Kanazawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus
Ippei Kanazawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Changes in Bone Mineral Density, Body Composition and Adiponectin Levels in Morbidly Obese Patients after Bariatric Surgery
Fernando Carrasco et al.
OBESITY SURGERY (2009)
Diabetes and fractures: an overshadowed association
Natasha B. Khazai et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
Use of thiazolidinediones and fracture risk
Christian Meier et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Relationship between osteocalcin and glucose metabolism in postmenopausal women
Jee-Aee Im et al.
CLINICA CHIMICA ACTA (2008)
The murine glucagon-like peptide-1 receptor is essential for control of bone resorption
Chizumi Yamada et al.
ENDOCRINOLOGY (2008)
Biomarkers for osteoporosis management - Utility in diagnosis, fracture risk prediction and therapy monitoring
Patrick Garnero
MOLECULAR DIAGNOSIS & THERAPY (2008)
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis
P. Vestergaard
OSTEOPOROSIS INTERNATIONAL (2007)
Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus
P Gerdhem et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.
II de Liefde et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake
CS Riedt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Octreotide abolishes the acute decrease in bone turnover in response to oral glucose
JA Clowes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Bone mineral changes in obese women during a moderate weight loss with and without calcium supplementation
LB Jensen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Share Paper
